DK0640344T3 - Ursodesoxycholsyreholdigt lægemiddel i flydende administreringsform - Google Patents

Ursodesoxycholsyreholdigt lægemiddel i flydende administreringsform

Info

Publication number
DK0640344T3
DK0640344T3 DK94810472T DK94810472T DK0640344T3 DK 0640344 T3 DK0640344 T3 DK 0640344T3 DK 94810472 T DK94810472 T DK 94810472T DK 94810472 T DK94810472 T DK 94810472T DK 0640344 T3 DK0640344 T3 DK 0640344T3
Authority
DK
Denmark
Prior art keywords
active compound
children
addition
liquid
bitterness
Prior art date
Application number
DK94810472T
Other languages
Danish (da)
English (en)
Inventor
Josef Olaf Widauer
Original Assignee
Medichemie Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Medichemie Ag filed Critical Medichemie Ag
Application granted granted Critical
Publication of DK0640344T3 publication Critical patent/DK0640344T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Steroid Compounds (AREA)
DK94810472T 1993-08-30 1994-08-16 Ursodesoxycholsyreholdigt lægemiddel i flydende administreringsform DK0640344T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH256793 1993-08-30

Publications (1)

Publication Number Publication Date
DK0640344T3 true DK0640344T3 (da) 1999-07-05

Family

ID=4236712

Family Applications (1)

Application Number Title Priority Date Filing Date
DK94810472T DK0640344T3 (da) 1993-08-30 1994-08-16 Ursodesoxycholsyreholdigt lægemiddel i flydende administreringsform

Country Status (8)

Country Link
US (1) US5534505A (ja)
EP (1) EP0640344B1 (ja)
JP (1) JP3631782B2 (ja)
AT (1) ATE171874T1 (ja)
CA (1) CA2130787C (ja)
DE (1) DE59407041D1 (ja)
DK (1) DK0640344T3 (ja)
ES (1) ES2121599T3 (ja)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7303768B2 (en) * 1998-07-24 2007-12-04 Seo Hong Yoo Preparation of aqueous clear solution dosage forms with bile acids
US7772220B2 (en) * 2004-10-15 2010-08-10 Seo Hong Yoo Methods and compositions for reducing toxicity of a pharmaceutical compound
US20050158408A1 (en) * 1998-07-24 2005-07-21 Yoo Seo H. Dried forms of aqueous solubilized bile acid dosage formulation: preparation and uses thereof
EP1113785B1 (en) * 1998-07-24 2005-04-13 Seo Hong Yoo Clear aqueous solutions of bile acids
CA2406930C (en) * 2000-02-04 2011-02-15 Seo Hong Yoo Preparation of aqueous clear solution dosage forms with bile acids
ATE327771T1 (de) * 2000-04-20 2006-06-15 Bioprogress Spa Verfahren zur herstellung ursodeoxycholsäure enthaltender pharmazeutischer zusammensetzungen in flüssiger form
US7145125B2 (en) 2003-06-23 2006-12-05 Advanced Optical Technologies, Llc Integrating chamber cone light using LED sources
KR101144647B1 (ko) * 2003-10-31 2012-05-08 와카모토 세이야꾸 가부시끼가이샤 가역성 열 겔화 수성 조성물
JP2008507504A (ja) * 2004-07-22 2008-03-13 ファイザー・プロダクツ・インク 溶解遅延形態の薬物及び／又は溶解増進形態のシクロデキストリンを含む味マスキング製剤
JP2008511651A (ja) * 2004-08-30 2008-04-17 セオ ホン ユー 局所虚血モデルでの可溶化ｕｄｃａの神経保護効果
KR20070084211A (ko) * 2004-10-15 2007-08-24 유서홍 약제학적 화합물의 독성을 감소시키기 위한 방법 및 조성물
KR101358078B1 (ko) * 2004-11-01 2014-02-06 주식회사 유스팜인터내셔널 근위축성 측삭 경화증의 신경퇴행을 감소시키기 위한 방법및 조성물
WO2008025560A1 (en) * 2006-09-01 2008-03-06 Pari Pharma Gmbh Methods for taste masking of nebulised compositions for nasal and pulmonary inhalation therapy
JP2010503667A (ja) * 2006-09-15 2010-02-04 ホン ユー，ソ 大腸疾患用胆汁製剤
GB0817969D0 (en) * 2008-10-01 2008-11-05 Axcess Ltd Pharmaceutical composition
EP2208497A1 (en) 2009-01-15 2010-07-21 Charité-Universitätsmedizin Berlin (Charité) Use of Ursodeoxycholic acid (UDCA) for enhancing the general health condition of a tumor patient
JP6217938B2 (ja) 2011-10-28 2017-10-25 ルメナ ファーマシューティカルズ エルエルシー 小児の胆汁うっ滞性肝疾患の処置のための胆汁酸再循環阻害剤
US10016357B2 (en) * 2012-03-22 2018-07-10 The Beauty Factory, Llc Personal lubricants
ES2741498T3 (es) 2013-06-21 2020-02-11 Dode Sa Contenedor plegable
WO2016019066A1 (en) * 2014-07-29 2016-02-04 University Of Tennessee Research Foundation Composition and method for treating liver disease
WO2021099973A1 (en) 2019-11-22 2021-05-27 Shilpa Medicare Limited Injectable compositions of ursodeoxycholic acid
CN115068418B (zh) * 2022-07-20 2022-10-28 奥信阳光(北京)药业科技有限公司 一种熊去氧胆酸口服溶液及其制备方法
WO2024144482A1 (en) * 2022-12-30 2024-07-04 Humanis Saglik Anonim Sirketi Pharmaceutical oral suspension compositions comprising chenodeoxycholic acid (cdca) as active ingredient and other relevant excipients

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3639597A (en) * 1968-02-02 1972-02-01 Merck & Co Inc Pharmaceutical compositions containing cholanic acid conjugates
DE2757641C2 (de) * 1977-12-23 1980-03-06 Rowa Ltd., Bantry, Cork (Irland) Verwendung von cis-(33Ä-Trimethylcyclohexanol zur Behandlung von Galleleiden
JPS5522616A (en) * 1978-08-04 1980-02-18 Tokyo Tanabe Co Ltd Bile acid inclusion compound and injection containing the same
US4264583A (en) * 1979-07-25 1981-04-28 The Procter & Gamble Company Gallstone dissolution compositions and method
JPS62153220A (ja) * 1985-12-27 1987-07-08 Tokyo Tanabe Co Ltd 胆汁酸内用水剤
IT1245889B (it) * 1991-04-12 1994-10-25 Alfa Wassermann Spa Formulazioni farmaceutiche per uso orale gastroresistenti contenenti sali di acidi biliari.

Also Published As

Publication number Publication date
DE59407041D1 (de) 1998-11-12
CA2130787C (en) 2006-12-05
EP0640344A1 (de) 1995-03-01
US5534505A (en) 1996-07-09
ES2121599T3 (es) 1998-12-01
JPH0782150A (ja) 1995-03-28
EP0640344B1 (de) 1998-10-07
CA2130787A1 (en) 1995-03-01
JP3631782B2 (ja) 2005-03-23
ATE171874T1 (de) 1998-10-15

Similar Documents

Publication Publication Date Title
DK0640344T3 (da) Ursodesoxycholsyreholdigt lægemiddel i flydende administreringsform
US4661354A (en) Topical treatment of herpes simplex with a zinc sulfate-camphor water solution
US4711906A (en) Liquid diclofenac preparations
CY2503B1 (en) Novel formulations for the transdermal administration of fluoxetine acetate and fluoxetine maleate.
WO2002064148A3 (en) Oral formulations containing mucopolysaccharide for small intestine delivery and their use in the treatment circulatory disorders
KR940018089A (ko) 내부조직의 방사선 손상에 대한 예방 및 처치방법
US4789660A (en) Insulin administration using methyl and propyl paraben
DE69913116T2 (de) Orale flüssige lösung enthaltend das antidepressivum mirtazapine
KR20010034240A (ko) 약학 조성물
EP1450825B1 (de) Verwendung von selenithältigen verbindungen zur topischen oder bukkalen anwendung
CA2487245A1 (en) An injection made from ixeris sonchifolia hance for treatment of cardio-cerebral vascular diseases and fundus diseases and method of producing thereof
US20220378803A1 (en) Injectable compositions of ursodeoxycholic acid
US4079133A (en) Safer method for dissolving gallstones combining hyodeoxycholic acid with chenodeoxycholic acids
RU2002135599A (ru) Способ повышения антиокислительного потенциала селенсодержащих водных растворов
US5955456A (en) Injectable pharmaceutical composition comprising ursodesoxycholic acid or tauroursodesoxycholic acid, a strong base and tromethamol
ATE241959T1 (de) Formulierungen von steroidlösungen zur inhalativen verabreichung
DE59408028D1 (de) Capsaicin enthaltendes Arzneimittel zur Behandlung chronischer Rhinopathie
JPH0376291B2 (ja)
EP1297838A4 (en) PRALMORELIN-CONTAINED NOSE DROP PREPARATIONS
JPH11139970A (ja) 経口液剤
DE3502099A1 (de) Therapeutisches, peptid- und/oder aminosaeurehaltiges mittel
KR900701263A (ko) 이보파민의 수용성 산 부가 염을 포함하는 안과용 약학 조성물
DE68901852D1 (de) Primycin-loesungen.
JPS62175427A (ja) 塗布勃起剤
DK200000687A (da) Middel til forsøgelse af afgivelsen af cerebral acetylcholin